
A treatment approach to central serous chorioretinopathy
Central serous chorioretinopathy (CSCR) is a commonly encountered chorioretinal disorder affecting working-age adults, the majority of whom (especially in acute presentations) achieve spontaneous resolution of subretinal fluid and visual improvement within three to six months1.
2 min read

